Stay updated with breaking news from Rev Dis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UCB receives European Commission approval for BIMZELX[®]▼ as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa ...
FDA Accepts Supplemental Biologics License Applications for BIMZELX[®] for Moderate to Severe Hidradenitis Suppurativa and Additional 2mL Device Presentations ...
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the...
CTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic Symptoms ADZYNMA is the First and Only Recombinant ADAMTS13 Enzyme...
“Listen to your heart.” Researchers investigated the risks of cardiometabolic disease, heart failure, and mortality in bipolar disorder in a population-based cohort study.